0001127602-13-017250.txt : 20130517
0001127602-13-017250.hdr.sgml : 20130517
20130517121230
ACCESSION NUMBER: 0001127602-13-017250
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130515
FILED AS OF DATE: 20130517
DATE AS OF CHANGE: 20130517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAPA JOSEPH C
CENTRAL INDEX KEY: 0001242215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19725
FILM NUMBER: 13853928
MAIL ADDRESS:
STREET 1: C/O WATSON PHARMACEUTICALS INC
STREET 2: 311 BONNIE CIRCLE
CITY: CORONA
STATE: CA
ZIP: 92880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERRIGO CO
CENTRAL INDEX KEY: 0000820096
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 382799573
STATE OF INCORPORATION: MI
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
BUSINESS PHONE: 2696738451
MAIL ADDRESS:
STREET 1: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2013-05-15
0000820096
PERRIGO CO
PRGO
0001242215
PAPA JOSEPH C
C/O PERRIGO COMPANY
515 EASTERN AVENUE
ALLEGAN
MI
49010
1
1
1
President and CEO
Chairman
Common Stock
2013-05-15
4
M
0
5000
35.85
A
105000
D
Common Stock
2013-05-15
4
S
0
3800
120.3596
D
101200
D
Common Stock
2013-05-15
4
S
0
1200
121.0005
D
100000
D
Employee Stock Option Right to Buy
35.85
2013-05-15
4
M
0
5000
0
D
2018-08-25
Common Stock
5000
53963
D
This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on November 8, 2012. This 10b5-1 sales plan will expire on the close of business November 8, 2013.
The price in column 4 is a weighted average. The prices actually received ranged from $119.86 to $120.86. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
The price in column 4 is a weighted average. The prices actually received ranged from $120.93 to $121.11. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Exercisable in 3 equal annual installments beginning 8/25/09.
/s/ Joseph C. Papa
2013-05-16